Abstract
Accurate pre-treatment evaluation including prostate multiparametric MRI (mpMRI) and prostate biopsy is required to efficiently discriminate clinically significant prostate cancer (csPC) from clinically insignificant prostate cancer (cis PC). On the other hand, as one solution to the limitations of standard systematic transrectal ultrasonography (TRUS)-guided prostate biopsy including the underestimation of tumor aggressiveness PC such as the Gleason score (GS), the false negative result for anterior lesion, and the overtreatment for detection of cis PC such as small PC with GS 3 + 3, the MRI-ultrasound (US) fusion-guided biopsy is becoming a gradually used method for prostate-targeted biopsy.1 Therefore, the aim of this study was to report our early experience with MRI-US fusion-guided prostate biopsy in Japanese men with elevated prostate-specific antigen (PSA) levels.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
